Professional Media briefs

Share this article:
Slack is giving its Orthopedics Today website, OrthoSuperSite.com, a redesign. The site will feature a new look along with new formats for its news, journal reviews, videos, blogs, interactive commentary and reader feedback. The site, which incorporates Orthopedics Today Europe, Orthopedics, Athletic Training & Sports Healthcare and Orthopedics Hyperguide, boasts 81,431 monthly unique visitors and 213,967 monthly page views.

Lippincott Williams & Wilkins launched Female Pelvic Medicine & Reconstructive Surgery, the official journal of The American Urogynecologic Society. It's a retitling of LWW's Journal of Pelvic Medicine & Surgery, but it broadens the bimonthly's reach to cover the entire field of female pelvic medicine and reconstructive surgery, the society and the publisher said.

Gold Standard/Elsevier launched Clinical Pharmacology Mobile, a mobile device-optimized site offering users access to the features and functions of Clinical Pharmacology, an electronic drug information and medication management reference. The site lets users search by trade or generic name, indication, contraindication/precaution or adverse reaction, and to browse by monograph or classification.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?